A phase I/II study of docetaxel in combination with pegylated liposomal doxorubicin in metastatic castration-resistant prostate cancer
Authors (first, second and last of 6)
Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly with experimental therapeutics with the field of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies in oncology and hematology. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.
- Covers clinical and experimental research in oncology and hematology
- Focuses on experimental therapeutics in the field of immunotherapy and chemotherapy
- Coverage includes immunobiology, pathogenesis, and treatment of malignant tumors
Journal information
- Editor-in-Chief
-
- Kenneth J. Pienta
- Publishing model
- Hybrid. Learn about publishing OA with us
Journal metrics
- 2.834 (2019)
- Impact factor
- 2.640 (2019)
- Five year impact factor
- 15 days
- Submission to first decision
- 62 days
- Submission to acceptance
- 205,525 (2019)
- Downloads
Latest issue
Latest articles
-
-
-
Transcription factor YY1 mediates epithelial–mesenchymal transition through the TGFβ signaling pathway in bladder cancer
Authors (first, second and last of 7)
-
-
Cinnamaldehyde induces endogenous apoptosis of the prostate cancer-associated fibroblasts via interfering the Glutathione-associated mitochondria function
Authors (first, second and last of 12)
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
-
Featured Article: Perspectives in Oncology: a new article type for Medical Oncology
We invite you to read an Open Access editorial from the April 2020 issue of Medical Oncology: Perspectives in Oncology: a new article type for Medical Oncology.
About this journal
- Electronic ISSN
- 1559-131X
- Print ISSN
- 1357-0560
- Abstracted and indexed in
-
- BIOSIS
- Biological Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Current Contents/Clinical Medicine
- Dimensions
- EBSCO Biomedical Reference Collection
- EBSCO CINAHL
- EBSCO Discovery Service
- EMBASE
- Elsevier Biobase
- Google Scholar
- INIS Atomindex
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Medical Database
- ProQuest Pharma Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SciSearch)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
-
© Springer Science+Business Media, LLC, part of Springer Nature
